In order to validate further the model of chemerin presentation by CCRL2, we could demonstrate the binding of a GFP-chemerin fusion protein on the surface of CCRL2-overexpressing tumor cells by immunofluorescence. The gene discussed is RARRES2; the disease is neoplasm.